Table 1 Baseline characteristics of studies included in meta-analysis
References | Sample size | Mean age, years | Gender (male/female) | Gartland type | Follow-up, months | ||||
|---|---|---|---|---|---|---|---|---|---|
MLP | LP | MLP | LP | MLP | LP | MLP | LP | ||
Foead et al. [31] | 34 | 32 | NA | NA | NA | NA | II/III | NA | NA |
Kocher et al. [30] | 24 | 28 | 5.7 | 6.1 | 13/11 | 10/18 | III | 3 | 3 |
Tripuraneni et al. [29] | 20 | 20 | 5.5 | 4.3 | NA | NA | II/III | 1.8 | 2.2 |
Gaston et al. [28] | 57 | 47 | 6.2 | 5.7 | 31/26 | 22/25 | III | NA | NA |
Anwar et al. [32] | 25 | 25 | NA | NA | NA | NA | II/III | 6 | 6 |
Maity et al. [27] | 80 | 80 | 6.24 | 6.12 | 48/32 | 51/29 | II/III | 3 | 3 |
Shah and Arif [33] | 100 | 100 | 6.51 | 5.83 | 80/20 | 78/22 | II/III | 3 | 3 |
Abdel Karim et al. [26] | 30 | 30 | NA | NA | NA | NA | II/III | 3 | 3 |
Prashant et al. [25] | 31 | 31 | 8.55 | 8.25 | 22/9 | 23/8 | III | 8.4 | 8.8 |
Naik et al. [24] | 29 | 28 | 6.28 | 7.2 | 20/9 | 16/12 | III | 5.7 | 5.9 |
Naveen and Chaitanya [34] | 20 | 20 | 7.37 | 7.62 | 12/8 | 13/7 | II/III | 6 | 6 |
Patil et al. [35] | 15 | 15 | NA | NA | 10/5 | 9/6 | III | 6 | 6 |
Arun et al. [36] | 30 | 38 | NA | NA | NA | NA | II/III | 6 | 6 |
Afaque et al. [23] | 40 | 37 | 7.2 | 6.8 | 27/13 | 21/16 | II/III/IV | 3 | 3 |
Abubeih et al. [37] | 33 | 34 | 5.4 | 4.9 | 24/9 | 21/13 | III | 3 | 3 |
Palange et al. [38] | 15 | 15 | 6.52 | 7.41 | NA | NA | III | 11.43 | 10.36 |
Othman and Hamawand [39] | 15 | 15 | 7.02 | 6.44 | 11/4 | 9/6 | III | 2.4 | 3.1 |
Natalin et al. [22] | 19 | 24 | NA | NA | NA | NA | III | 6 | 6 |
Singh et al. [40] | 31 | 30 | 8.54 | 8.26 | 23/8 | 22/8 | III | 8.4 | 8.8 |